Page 3 - Celcuity Inc News Today

Commodore Capital LP lifted its holdings in shares of Celcuity Inc. (NASDAQ:CELC – Free Report) by 3.8% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,444,141 shares of the company’s stock after buying an additional 53,369 shares during the period. […]

MINNEAPOLIS, Dec. 06, 2023 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today presented data from preclinical studies evaluating gedatolisib

Celcuity Inc. (NASDAQ:CELC – Get Free Report) was the target of a significant drop in short interest during the month of November. As of November 15th, there was short interest totalling 366,900 shares, a drop of 10.6% from the October 31st total of 410,300 shares. Based on an average trading volume of 61,300 shares, the […]

MINNEAPOLIS, Nov. 22, 2023 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted...

Research Analysts’ updated eps estimates for Monday, November 13th: Aadi Bioscience (NASDAQ:AADI) had its price target reduced by HC Wainwright from $45.00 to $36.00. HC Wainwright currently has a buy rating on the stock. Annexon (NASDAQ:ANNX) had its price target trimmed by Needham & Company LLC from $24.00 to $16.00. They currently have a buy […]

Operator: Greetings, and welcome to the Celcuity Third Quarter 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode.

MARKET WRAPS Watch For: Remembrance Day observed in Canada, markets open. APEC Finance Ministers meeting concludes Todays Top Headlines/Must Reads: - The Clearest Sign Yet That... -November 13, 2023 at 06:12 am EST - MarketScreener

06.11.2023 - MINNEAPOLIS, Nov. 06, 2023 (GLOBE NEWSWIRE) - Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that it will release its financial results for the third ...

MINNEAPOLIS, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted...

MDxHealth (NASDAQ:MDXH – Get Free Report) and Celcuity (NASDAQ:CELC – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, valuation, dividends, analyst recommendations, profitability, institutional ownership and earnings. Analyst Ratings This is a summary of recent ratings […]